Actively Recruiting
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
Led by Kiyuk Chang · Updated on 2025-01-03
1000
Participants Needed
1
Research Sites
334 weeks
Total Duration
On this page
Sponsors
K
Kiyuk Chang
Lead Sponsor
S
Seoul St. Mary's Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Prospective trials performed on type 2 diabetes patients without established cardiovascular disease has shown that SGLT2 inhibitors reduce cardiovascular risk. No studies have yet examined the occurrence of cardiovascular disease in patients with acute myocardial infarction. The investigators designed the current study to evaluate the most ideal oral hypoglycemic agent in type 2 diabetes patients undergoing percutaneous coronary intervention for acute myocardial infarction. The investigators hypothesize that the use of SGLT-2 inhibitors will reduce cardiovascular events and modify left ventricular remodeling after myocardial infarctions.
CONDITIONS
Official Title
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Acute myocardial infarction treated with percutaneous coronary intervention
- Type 2 diabetes mellitus
- Started SGLT2 inhibitors less than 1 month before or after PCI
You will not qualify if you...
- Type 1 diabetes mellitus
- Use of insulin or GLP-1 analogues
- Previous use of SGLT2 inhibitors
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul St. Mary's Hospital
Seoul, South Korea
Actively Recruiting
Research Team
K
Kiyuk Chang, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here